Literature DB >> 2558635

Studies on attenuation of rotavirus. A comparison in piglets between virulent virus and its attenuated derivative.

S Tzipori1, L Unicomb, R Bishop, J Montenaro, L M Vaelioja.   

Abstract

The development of rotavirus vaccines against acute gastroenteritis for human infants has been accorded a very high priority. Several vaccine candidates all of which are live cultivated strains of animal origin have been tested in humans. However the nature of attenuation of these viruses for humans is unknown. In this study we have attenuated a pig rotavirus by 15 sequential passages in cell culture after which the virus no longer causes diarrhoea in piglets. The pathogenesis of infection of the attenuated rotavirus strain (AT/76 P15) in gnotobiotic piglets was compared with that of the virulent parent strain (AT/76). The pattern of virus replication in the small intestine was judged by histology, disaccharidase assay, immunoperoxidase labelling of gut sections using group A specific rotavirus antibody, and rotavirus antigen assay of gut contents. The parent strain caused variable but extensive infection that resulted in the complete destruction of mature small intestinal enterocytes and villous contraction within 3 days. Membrane bound digestive enzymes were lost, and profound watery diarrhoea and dehydration resulted in causing piglets to become moribund. In contrast attenuated virus appeared to propagate at a much slower pace. Fewer infected epithelial cells were detected at any one time. Destruction of enterocytes was never extensive enough to cause marked mucosal changes in histology. Membrane bound digestive enzymes remained near normal levels and there was little or no diarrhoea. Virus replication ceased after 6 days. It is concluded that attenuation of the porcine rotavirus strain studied was associated with its decreased ability to propagate in enterocytes after adaption to culture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558635     DOI: 10.1007/BF01311081

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES.

Authors:  A DAHLQVIST
Journal:  Anal Biochem       Date:  1964-01       Impact factor: 3.365

2.  Gel electrophoresis of rotavirus RNA derived from six different animal species.

Authors:  M Smith; S Tzipori
Journal:  Aust J Exp Biol Med Sci       Date:  1979-12

3.  Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses.

Authors:  B S Coulson; L E Unicomb; G A Pitson; R F Bishop
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

4.  Reassortant rotaviruses as potential live rotavirus vaccine candidates.

Authors:  K Midthun; H B Greenberg; Y Hoshino; A Z Kapikian; R G Wyatt; R M Chanock
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Isolation and serotyping of animal rotaviruses and antigenic comparison with human rotaviruses. Brief report.

Authors:  M J Albert; L E Unicomb; S R Tzipori; R F Bishop
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Rotavirus shedding by newborn children.

Authors:  I Perez-Schael; G Daoud; L White; G Urbina; N Daoud; M Perez; J Flores
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

7.  Cell culture adaptation and propagation of a reovirus-like agent of calf diarrhea from a field outbreak in Nebraska.

Authors:  A L Fernelius; A E Ritchie; L G Classick; J O Norman; C A Mebus
Journal:  Arch Gesamte Virusforsch       Date:  1972

8.  Variation in virulence of bovine rotaviruses.

Authors:  J C Bridger; D H Pocock
Journal:  J Hyg (Lond)       Date:  1986-04

9.  Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children.

Authors:  E L Anderson; R B Belshe; J Bartram; F Crookshanks-Newman; R M Chanock; A Z Kapikian
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

10.  Asymptomatic endemic rotavirus infections in the newborn.

Authors:  I L Chrystie; B M Totterdell; J E Banatvala
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

View more
  6 in total

1.  Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype.

Authors:  B S Coulson; C Kirkwood
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Attachment and growth of human rotaviruses RV-3 and S12/85 in Caco-2 cells depend on VP4.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

3.  Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig model.

Authors:  L A Ward; L Yuan; B I Rosen; T L Tô; L J Saif
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  Direct inhibitory effect of rotavirus NSP4(114-135) peptide on the Na(+)-D-glucose symporter of rabbit intestinal brush border membrane.

Authors:  N Halaihel; V Liévin; J M Ball; M K Estes; F Alvarado; M Vasseur
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Development of an adult mouse model for studies on protection against rotavirus.

Authors:  R L Ward; M M McNeal; J F Sheridan
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.

Authors:  Jin-Tao Li; Jing Wei; Hong-Xia Guo; Jiang-Bo Han; Nan Ye; Hai-Yang He; Tian-Tian Yu; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.